| Mrs Jessica A Hammerli, CRNA | |
|
181 W Meadow Dr, Vail, CO 81657 | |
| (970) 476-2451 | |
| (817) 877-0350 |
| Full Name | Mrs Jessica A Hammerli |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 181 W Meadow Dr, Vail, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144752635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN.0203734 (Colorado) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | APN.0993171-CRNA (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vail Health Hospital | Vail, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Partners Of Colorado | 0345520151 | 38 |
News Archive
Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $51.1 million, or an increase of 41% to $1.03 per diluted share, during the third quarter of 2009 as compared to $37.0 million, or $.73 per diluted share, during the comparable quarter of the prior year.
The tendency for extreme scarring is one reason many African Americans avoid plastic surgery and other surgical incisions. Though surgeons continue to develop less invasive techniques that minimize scarring, other options are needed to help these individuals who are prone to developing keloid scars.
Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.
We like to complain about our aches and pains, but rheumatism is not only the preserve of western society.
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-).
› Verified 1 days ago
| Entity Name | Anesthesia Partners Of Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457702409 PECOS PAC ID: 0345520151 Enrollment ID: O20161214000880 |
News Archive
Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $51.1 million, or an increase of 41% to $1.03 per diluted share, during the third quarter of 2009 as compared to $37.0 million, or $.73 per diluted share, during the comparable quarter of the prior year.
The tendency for extreme scarring is one reason many African Americans avoid plastic surgery and other surgical incisions. Though surgeons continue to develop less invasive techniques that minimize scarring, other options are needed to help these individuals who are prone to developing keloid scars.
Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.
We like to complain about our aches and pains, but rheumatism is not only the preserve of western society.
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jessica A Hammerli, CRNA Po Box 913001, Denver, CO 80291-3001 Ph: (817) 334-0530 | Mrs Jessica A Hammerli, CRNA 181 W Meadow Dr, Vail, CO 81657 Ph: (970) 476-2451 |
News Archive
Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $51.1 million, or an increase of 41% to $1.03 per diluted share, during the third quarter of 2009 as compared to $37.0 million, or $.73 per diluted share, during the comparable quarter of the prior year.
The tendency for extreme scarring is one reason many African Americans avoid plastic surgery and other surgical incisions. Though surgeons continue to develop less invasive techniques that minimize scarring, other options are needed to help these individuals who are prone to developing keloid scars.
Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.
We like to complain about our aches and pains, but rheumatism is not only the preserve of western society.
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-).
› Verified 1 days ago
Sally Agnoletto, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 303-422-9438 Fax: 303-422-9474 | |
Mrs. Anni B Drago, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-476-2451 Fax: 817-877-0350 | |
Anne M Hatch, APRN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-456-2451 |